IDEXX Laboratories, Inc. (IDXX)
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It?
IDXX shares jump 39% in a year, as CAG Diagnostics' recurring revenues, diagnostic innovations and software growth fuel momentum.
Is This the Right Time to Retain IDXX Stock in Your Portfolio?
IDEXX rides on strong CAG diagnostics growth, innovations and cloud software momentum, but solvency concerns and macro pressures cloud the outlook.
Why Is Idexx (IDXX) Up 0.5% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 guidance calls for steady growth.
Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates
Idexx Laboratories (IDXX) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.62 per share a year ago.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
Curious about Idexx (IDXX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Idexx (IDXX) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
